Prof. Dr. med. Gerhard Huber
Opportunities and Limits in Salvage Surgery in Persistent or Recurrent Head and Neck Squamous Cell Carcinoma
Huber G. Opportunities and Limits in Salvage Surgery in Persistent or Recurrent Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021; 13
18.05.2021Opportunities and Limits in Salvage Surgery in Persistent or Recurrent Head and Neck Squamous Cell Carcinoma
18.05.2021Cancers (Basel) 2021; 13
Huber Gerhard
Impact of the new TNM Staging System (8th edition) on oral tongue cancers
Ammann Y, Beutner U, Vital D, Morand G, Broglie Daeppen M, Born D, Stöckli S, Huber G. Impact of the new TNM Staging System (8th edition) on oral tongue cancers. Swiss Med Wkly 2021; 151:w20493.
02.05.2021Impact of the new TNM Staging System (8th edition) on oral tongue cancers
02.05.2021Swiss Med Wkly 2021; 151:w20493
Ammann Yanic, Beutner Ulrich, Vital Domenic Gian, Morand Grégoire, Broglie Daeppen Martina A, Born Diana, Stöckli Sandro, Huber Gerhard
High-grade Salivary Gland Adenocarcinoma Harboring ETV6-NTRK3 Fusion: Defined by Morphology or Molecular Aberration?
Rupp N, Nemes C, Rushing E, Huber G, Freiberger S. High-grade Salivary Gland Adenocarcinoma Harboring ETV6-NTRK3 Fusion: Defined by Morphology or Molecular Aberration?. Head Neck Pathol 2021; 15:1082-1084.
05.02.2021High-grade Salivary Gland Adenocarcinoma Harboring ETV6-NTRK3 Fusion: Defined by Morphology or Molecular Aberration?
05.02.2021Head Neck Pathol 2021; 15:1082-1084
Rupp Niels J, Nemes Constanze, Rushing Elisabeth J, Huber Gerhard, Freiberger Sandra N
Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
Riesterer O, Pruschy M, Bender S, Sharma A, Bogowicz M, Tanadini-Lang S, Stieb S, Bertogg K, Weber S, Ikenberg K, Huber G, Schmid S, Bredell M, Veit-Haibach P, Rordorf T, Held U, Glanzmann C, Studer G. Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study. Radiother Oncol 2020; 150:62-69.
12.06.2020Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
12.06.2020Radiother Oncol 2020; 150:62-69
Riesterer Oliver, Pruschy Martin, Bender Sabine, Sharma Ashish, Bogowicz Marta, Tanadini-Lang Stephanie, Stieb Sonja, Bertogg Kaja, Weber Sandra, Ikenberg Kristian, Huber Gerhard, Schmid Stephan, Bredell Marius, Veit-Haibach Patrick, Rordorf Tamara, Held Ulrike, Glanzmann Christoph, Studer Gabriela
Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma
de Galiza Barbosa F, Stolzmann P, Huellner M, Huber G, Pruschy M, Studer G, Stieb S, Tanadini-Lang S, Riesterer O, Veit-Haibach P. Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma. Head & neck 2019; 42:163-170.
09.11.2019Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma
09.11.2019Head & neck 2019; 42:163-170
de Galiza Barbosa Felipe, Stolzmann Paul, Huellner Martin W, Huber Gerhard, Pruschy Martin, Studer Gabriela, Stieb Sonja, Tanadini-Lang Stephanie, Riesterer Oliver, Veit-Haibach Patrick
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers)
Broglie M, Negri S, Rothschild S, Giger R, Beffa L, Ballerini G, Huber G, Zwahlen D, Simon C, Putora P, Siano M, Henke G, Dulguerov P, Elicin O. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers). Front Oncol 2019; 9:1128.
24.10.2019A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers)
24.10.2019Front Oncol 2019; 9:1128
Broglie Martina A, Negri Sandro V, Rothschild Sacha, Giger Roland, Beffa Lorenza, Ballerini Giorgio, Huber Gerhard, Zwahlen Daniel, Simon Christian, Putora Paul Martin, Siano Marco, Henke Guido, Dulguerov Pavel, Elicin Olgun
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology)
Siano M, Negri S, Rothschild S, Giger R, Beffa L, Ballerini G, Huber G, Zwahlen D, Simon C, Putora P, Henke G, Broglie M, Dulguerov P, Elicin O. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology). Front Oncol 2019; 9:1127.
24.10.2019A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology)
24.10.2019Front Oncol 2019; 9:1127
Siano Marco, Negri Sandro V, Rothschild Sacha, Giger Roland, Beffa Lorenza, Ballerini Giorgio, Huber Gerhard, Zwahlen Daniel, Simon Christian, Putora Paul Martin, Henke Guido, Broglie Martina A, Dulguerov Pavel, Elicin Olgun
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology)
Elicin O, Dulguerov P, Negri S, Rothschild S, Giger R, Beffa L, Ballerini G, Huber G, Zwahlen D, Simon C, Broglie M, Siano M, Putora P, Henke G. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology). Front Oncol 2019; 9:1126.
24.10.2019A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology)
24.10.2019Front Oncol 2019; 9:1126
Elicin Olgun, Dulguerov Pavel, Negri Sandro V, Rothschild Sacha, Giger Roland, Beffa Lorenza, Ballerini Giorgio, Huber Gerhard, Zwahlen Daniel, Simon Christian, Broglie Martina A, Siano Marco, Putora Paul Martin, Henke Guido
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery)
den Hollander J, Negri S, Rothschild S, Giger R, Beffa L, Ballerini G, Huber G, Zwahlen D, Simon C, Putora P, Siano M, Henke G, Broglie M, Elicin O. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery). Front Oncol 2019; 9:1125.
24.10.2019A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery)
24.10.2019Front Oncol 2019; 9:1125
den Hollander Jürgen, Negri Sandro V, Rothschild Sacha, Giger Roland, Beffa Lorenza, Ballerini Giorgio, Huber Gerhard, Zwahlen Daniel, Simon Christian, Putora Paul Martin, Siano Marco, Henke Guido, Broglie Martina A, Elicin Olgun
The expression of PD-L1 in salivary gland carcinomas
Vital D, Ikenberg K, Moch H, Rössle M, Huber G. The expression of PD-L1 in salivary gland carcinomas. Sci Rep 2019; 9:12724.
04.09.2019The expression of PD-L1 in salivary gland carcinomas
04.09.2019Sci Rep 2019; 9:12724
Vital Domenic, Ikenberg Kristian, Moch Holger, Rössle Matthias, Huber Gerhard
Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suv) In Laryngeal and Hypopharyngeal Cancer
Werner J, Hüllner M, Rupp N, Huber A, Broglie M, Huber G, Morand G. Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suv) In Laryngeal and Hypopharyngeal Cancer. Sci Rep 2019; 9:8972.
20.06.2019Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suv) In Laryngeal and Hypopharyngeal Cancer
20.06.2019Sci Rep 2019; 9:8972
Werner Jonas, Hüllner Martin W, Rupp Niels J, Huber Alexander M, Broglie Martina A, Huber Gerhard, Morand Grégoire B
First clinico-pathological evidence of a non PSMA-related uptake mechanism for Ga-PSMA-11 in salivary glands
Rupp N, Schibli R, Eberli D, Huber G, Morand G, Messerli M, Ferraro D, Mühlematter U, Müller J, Töpfer A, Lenggenhager D, Pizzuto D, Umbricht C, Burger I. First clinico-pathological evidence of a non PSMA-related uptake mechanism for Ga-PSMA-11 in salivary glands. J Nucl Med 2019
08.02.2019First clinico-pathological evidence of a non PSMA-related uptake mechanism for Ga-PSMA-11 in salivary glands
08.02.2019J Nucl Med 2019
Rupp Niels J, Schibli Roger, Eberli Daniel, Huber Gerhard, Morand Grégoire B, Messerli Michael, Ferraro Daniela A, Mühlematter Urs Jacob, Müller Julian, Töpfer Antonia, Lenggenhager Daniela, Pizzuto Daniele A, Umbricht Christoph A, Burger Irene A
Long-term speech and swallowing function after primary resection and sentinel node biopsy for early oral squamous cell carcinoma
Romer C, Broglie Daeppen M, Mueller M, Huber G, Güsewell S, Stöckli S. Long-term speech and swallowing function after primary resection and sentinel node biopsy for early oral squamous cell carcinoma. Oral Oncol 2019; 89:127-132.
09.01.2019Long-term speech and swallowing function after primary resection and sentinel node biopsy for early oral squamous cell carcinoma
09.01.2019Oral Oncol 2019; 89:127-132
Romer C A E, Broglie Daeppen M A, Mueller M, Huber Gerhard, Güsewell Sabine, Stöckli Sandro
Recurrent unilateral peripheral facial palsy in a patient with an enlarged styloid process
Péus D, Kollias S, Huber G. Recurrent unilateral peripheral facial palsy in a patient with an enlarged styloid process. Head & neck 2018
24.12.2018Recurrent unilateral peripheral facial palsy in a patient with an enlarged styloid process
24.12.2018Head & neck 2018
Péus Dominik, Kollias Spyros S, Huber Gerhard
Preoperative assessment of CD44-mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma
Morand G, Ikenberg K, Vital D, Cardona I, Moch H, Stöckli S, Huber G. Preoperative assessment of CD44-mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma. Head & neck 2018; 41:950-958.
18.12.2018Preoperative assessment of CD44-mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma
18.12.2018Head & neck 2018; 41:950-958
Morand Grégoire B, Ikenberg Kristian, Vital Domenic G, Cardona Isabel, Moch Holger, Stöckli Sandro, Huber Gerhard
Use of MRI and FDG-PET/CT to predict fixation of advanced hypopharyngeal squamous cell carcinoma to prevertebral space
Meerwein C, Pizzuto D, Vital D, Morand G, Stolzmann P, Huber G, Huellner M. Use of MRI and FDG-PET/CT to predict fixation of advanced hypopharyngeal squamous cell carcinoma to prevertebral space. Head & neck 2018
18.12.2018Use of MRI and FDG-PET/CT to predict fixation of advanced hypopharyngeal squamous cell carcinoma to prevertebral space
18.12.2018Head & neck 2018
Meerwein Christian M, Pizzuto Daniele A, Vital Domenic, Morand Grégoire B, Stolzmann Paul, Huber Gerhard, Huellner Martin W
Comparison of PI3K Pathway in HPV-Associated Oropharyngeal Cancer With and Without Tobacco Exposure
Kiessling S, Broglie M, Soltermann A, Huber G, Stöckli S. Comparison of PI3K Pathway in HPV-Associated Oropharyngeal Cancer With and Without Tobacco Exposure. Laryngoscope Investig Otolaryngol 2018; 3:283-289.
09.08.2018Comparison of PI3K Pathway in HPV-Associated Oropharyngeal Cancer With and Without Tobacco Exposure
09.08.2018Laryngoscope Investig Otolaryngol 2018; 3:283-289
Kiessling Si-Young, Broglie Martina Anja, Soltermann Alex, Huber Gerhard, Stöckli Sandro
Maximum Standardized Uptake Value (SUV) of Primary Tumor Predicts Occult Neck Metastasis in Oral Cancer
Morand G, Vital D, Kudura K, Werner J, Stöckli S, Huber G, Huellner M. Maximum Standardized Uptake Value (SUV) of Primary Tumor Predicts Occult Neck Metastasis in Oral Cancer. Sci Rep 2018; 8:11817.
07.08.2018Maximum Standardized Uptake Value (SUV) of Primary Tumor Predicts Occult Neck Metastasis in Oral Cancer
07.08.2018Sci Rep 2018; 8:11817
Morand Grégoire B, Vital Domenic G, Kudura Ken, Werner Jonas, Stöckli Sandro, Huber Gerhard, Huellner Martin W
Contrast-enhanced 18F-FDG-PET/CT for Differentiating Tumour and Radionecrosis in Head and Neck Cancer: Our experience in 37 Patients
Meerwein C, Nakadate M, Stolzmann P, Vital D, Morand G, Zweifel D, Huber G, Huellner M. Contrast-enhanced 18F-FDG-PET/CT for Differentiating Tumour and Radionecrosis in Head and Neck Cancer: Our experience in 37 Patients. Clin Otolaryngol 2018; 43:1594-1599.
31.07.2018Contrast-enhanced 18F-FDG-PET/CT for Differentiating Tumour and Radionecrosis in Head and Neck Cancer: Our experience in 37 Patients
31.07.2018Clin Otolaryngol 2018; 43:1594-1599
Meerwein Christian M, Nakadate Masashi, Stolzmann Paul, Vital Domenic, Morand Grégoire B, Zweifel Daniel F, Huber Gerhard, Huellner Martin W
The expression of the cancer testis antigen MAGE A4: A favorable prognostic biomarker in salivary gland carcinomas related to low tumor grading
Vital D, Ikenberg K, Moch H, Roessle M, Huber G. The expression of the cancer testis antigen MAGE A4: A favorable prognostic biomarker in salivary gland carcinomas related to low tumor grading. Laryngoscope Investig Otolaryngol 2018; 3:182-190.
19.04.2018The expression of the cancer testis antigen MAGE A4: A favorable prognostic biomarker in salivary gland carcinomas related to low tumor grading
19.04.2018Laryngoscope Investig Otolaryngol 2018; 3:182-190
Vital Domenic, Ikenberg Kristian, Moch Holger, Roessle Matthias, Huber Gerhard